ABSTRACT BACKGROUND: P-glycoprotein (Pgp/MDR1) is an ATP-dependent, integral plasma-membrane efflux pump that is constitutively expressed on adult apical brush-border epithelium of renal proximal tubules. This Pgp/ MDR1 tissue distribution and localization affects the absorption, distribution, metabolism, and excretion of Pgp/MDR1 substrates. The ontogeny of rat Pgp/MDR1 is still doubtful, and such knowledge may be helpful in understanding age-related pharmacokinetics. The purpose of this study was to determine, whether Pgp/ MDR1 expression is altered during development. METHODS: Postnatal expression of Pgp was determined using immunohistochemical method. Tissue from Wistar rat were isolated on the 1st day (D1), 7th day (D7), 14th day (D14), 21st day of life (D21) and from adult animals (60 days old; Ad).
INTRODUCTION
ATP-binding cassette (ABC) superfamily now includes about 300 proteins, among the transporters of quite different compounds (1, 2, 3) . Proteins of this family are present in all living organisms. About fifty ABC proteins have been found in man and approximately the same number in mouse (4) . Since a great number of ABC proteins were discovered only recently, many of them are still poorly studied. Studies of ABC proteins are important both for medicine and biology because they concern problems of protection of all living cells. Human proteins of the ABC family are divided to seven subfamilies (class A to G) (4, 5) . The affiliation of each protein to a subfamily is determined by its domain organization, namely by the number and combination of transmembrane domains (TMDs) and ATP-binding domains (NBDs, nucleotide-binding domains) (6) . In total, there are 49 protein members in this family, but only three are well known for their multidrug resistance (7) . There are P-glycoprotein (Pgp/MDR1, ABCB1), MDR-associated protein (MRP1, ABCC1) and breast cancer resistance protein (BCRP, ABCG2). Pgp, paradigm ABC drug efflux transporter, is the first detected and to date the best characterized of the family of ABC drug efflux transporters. It gained worldwide attention about three decades ago for its role in the phenomenon of multidrug resistance in tumor cells (8, 9) . Subsequently, constitutive expression of Pgp/MDR1 has been described in a variety of other tissues including liver, intestine, kidney, pancreas, adrenal, capillary endothelium of blood-brain and blood-testis barrier, choroid plexus, placental trophoblast and others (10) . The polarized, apical membrane localization of Pgp/MDR1 causes that its substrates are prefeerentially translocated from basolateral to the apical side of the epithelium. Thus, Pgp/ MDR1 limits the influx and facilitates the efflux of its substrates, eventually preventing their intracellular accumulation. Many in vitro and in vivo studies demonstrated high
impact of Pgp/MDR1 on drug pharmacokinetics in these organs (10) . It is likely that Pgp/MDR1 and other ABCs have evolved in these "normal" tissues to protect them from potentially damaging effect of toxic compounds.
In the kidney, Pgp/MDR1 is expressed mainly at the apical (luminal) brush-border membrane of proximal tubular cells (11) and to lesser extent in the thick limb of Henle's loop, collecting ducts, and glomerular mesangium. Many substances are actively transported by Pgp/MDR1, e.g. calcium channel blockers, immunosuppressants, cardioactive glycosides, antibiotics, antineoplastic and severel others peptides and steroids (12, 13) . Thus Pgp/MDR1 functions as an efflux pump which represents a protective mechanism to exclude endogenous and exogenous toxins from normal cells and to ultimately excrete them into the bodily secretions. In humans, two genes (MDR1 and MDR2) encode this protein, whereas in rodents there are three homologs of this protein, mdr1 (mdr1b), mdr2, mdr3 (mdr1a) (14, 15, 16) .
The aim of the present study was to determine postnatal expression of Pgp/MDR1 in rat kidney by two widely used monoclonal antibodies for Pgp/MDR1: C219 and UIC2 .These antibodies are known to detect Pgp/MDR1 in paraffin-embedded histological tissue in many histopathological laboratories. The neonatal rat is a useful model for kidney developmental studies since rats are born with immature kidneys and there is considerable postnatal renal development.
MATERIAL AND METHODS

Animals
All procedures performed with animals adhered to the permission of the Committee for Ethical Control of Animal Experiments at Safarik University and the permission of the State Veterinary and Food Administration of the Slovak Republic (permission No. 7881/04-220/3). All efforts were made to minimize both the number animals and their suffering.
To acquire rat cubs, female Wistar rats were mated with males of the same strain overnight. Tissue from Wistar rat were isolated on the 1st day (D1), 7th day (D7), 14th day (D14), 21st day of life (D21) and from adult animals (60 days old; Ad) by ether anaesthesia. Three animals were killed on each day examined. The kidneys were obtained by medial laparotomy carried out in deeply anaesthetised animals. At the end of surgery rats were killed by overdose of ether. Rat kidneys were immersed in a neutral buffered formalin solution for 72 hours at room temperature. Tissue blocks were dehydrated in increasing alcohols and embedded in paraffin. Seven-micron-thick serial sections were cut and attached to the slide with alum gelatine. The slides were processed for immunohistochemistry.
Antibodies:
We have used the following primary monoclonal antibodies: mouse anti-MDR1, clone C219 (Signet Laboratories, Inc.) and mouse anti-MDR1, UIC2 -clone C494 (Santa Cruz Biotechnology, Inc.).
Immunohistochemical detection of Pgp:
For immunohistochemistry, paraffin embedded sections of the rat kidney were deparaffinized with xylene and rehydrated in decreasing ethanols to water. The slides were finally washed in phosphate-buffered saline containing 0.05 % Tween-20 (PBS-Tw), pH 7.6. Endogenous peroxidase activity was blocked by 0.3 % H202 in methanol for 30 minutes at room temperature. To re-establish an original conformation of epitopes modified after fixation, we performed antigen retrieval using a microwave (in sodium citrate solution for 2x5 minutes at 500 watts). Pgp/ MDR1 staining procedure continued by blocking nonspecific staining with milk buffer (5 % dry milk in TRIS buffer) for 30 minutes at room temperature. Primary antibodies were applied overnight in humidified chamber at 4˚C. After rinsing in PBS-Tw (3x5 minutes) the sections were subsequently incubated with the secondary antibody (30 minutes) and strepatavidin-M A R T I N I A N A 2 0 1 1 1 1 / 1 25 biotin (30 minutes) (Universal detection kit LSAB+KIT/HRP, Dako). Next, the sections were visualized with DAB (3.3'-diaminobenzidine tetrahydrochloride) at a concentration of 0.5 mg/ ml in Tris buffer, pH 7.6 and 0.015 % H2O2. Slides were stream-rinsed with tap water, counterstained with Mayer's hematoxylin for 2 minutes, washed in tap water, dried, mounted and coverslipped. Sections processed with omission of primary antibody served as control.
Semiquantitative evaluation
Immunostaining was assessed by two independent observers blinded to animal characteristics.
Expression of Pgp/MDR1 was evaluated separately using the following scale: 3+ = high level (91-100 % of positive cells), 2+ = medium level (11- 
RESULTS
Kidney of rat cubs
Using monoclonal antibody mouse anti-MDR1 clone C219 we have detected moderate immunopositivity for Pgp/MDR1 in all developmental stages (D1, D7, D14, D21). Employing semiquantitative evaluation of tissue samples we have found no differences in expression of Pgp/MDR1 in epithelial cells of proximal tubules. The remaining structures (epithelial cells of distal tubules, glomerulus and glomerular capsule) did not show any positivity for Pgp/MDR1.
Using monoclonal antibody mouse anti-MDR1 UIC2 -clone C494 we have detected in all developmental stages the same spatial protein distribution but its signal was significantly weaker.
Kidney of rat adults
Using both monoclonal antibodies (mouse anti-MDR1:clone C219 and mouse anti-MDR1:UIC2 -clone C494) we have observed expression of Pgp/MDR1 in epithelial cells of proximal tubules in adult kidney, too. Employing semiquantitative evaluation we have found no differences in expression of Pgp/MDR1 in all tissue samples. The immunoreactivity for this protein was strongly restricted to the apical membrane and weakly to the cytoplasm of proximal tubular cells. No signal for this protein in the other cells of rat kidney was found.
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DISCUSSION
Knowledge of the ontogeny about transport proteins involved in distribution and elimination of drugs is important for adequate interpretation of the results of safety studies in juvenile animals. Since rat is one of the most frequently species used in non-clinical testing we used this species in our study on the age-dependent changes in Pgp/MDR1 expression. We focused on the age shortly after birth until early adulthood of the animals (D1, D7, D14, D21, Ad). The transport proteins in the kidney are involved in the passage of compound through the tubular epithelial cells, prior to urinary excretion. Urinary excretion of drugs is a complex interplay of three mechanisms: glomerular filtration, tubular secretion, and tubular reabsorption. The basic prerequisite for excretion into urine is water solubility of drug and/or its metabolites as no transporting carrier is available in this body fluid. Accordingly, the primary mechanism for drug excretion is glomerular filtration, a passive process influenced by molecule size, concentration of unbound fraction of drug in plasma and renal blood perfusion. Tubular secretion and partly also reabsorption are active mechanisms requiring transporters. The function of renal proximal tubular epithelial cells is the most significant factor for active drug renal excretion (17) .
The large differences in ontogeny of the individual transport proteins were observed, with some transporters having the highest expression at birth (MRP1 and MRP3), and other having a more or less constant expression during development (MRP2 and BCRP) (18) . It was reported that Pgp/MDR expression increased up to Day 26, with a subsequent decrease to adult levels at Day 42 (18) . On the other hand, other authors found continuously increasing level of Pgp/MDR1 up to Day 60 (19) . In our study we have found relatively constant levels of Pgp/MDR1 protein from the birth to the adulthood.
It should be noted that all our data on transport protein is limited to actual functionality of Pgp/MDR1. The mRNA expression of this transporter was not studied such as in previous mentioned publications. The reason for the differences between the data obtained in our study and those already published, as well as the differences between individual publications, are most likely related to differences in methodology (sample preparation, differences in diet, etc.).
Despite these differences, the results indicate that expression of majority of the transport proteins studied vary during development. Cellular and tissue distribution as well as elimination of transported substrates will therefore also change during development. Knowledge of these ontogenic differences in absorption, distribution, metabolism and excretion (ADME) processes of test compound in development may help to interpret differences in toxicity observed between adult, neonate and young animals.
